Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Utility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphoma.

Pittman M, Treese S, Chen L, Frater JL, Nguyen TT, Hassan A, Kreisel F.

Arch Pathol Lab Med. 2013 Nov;137(11):1610-8. doi: 10.5858/arpa.2012-0313-OA.

PMID:
24168498
2.

Flow cytometric analysis of cerebrospinal fluid has low diagnostic yield in samples without atypical morphology or prior history of hematologic malignancy.

Collie AM, Hill BT, Stevens GH, Fenner K, Gazdick E, Hsi ED.

Am J Clin Pathol. 2014 Apr;141(4):515-21. doi: 10.1309/AJCP8IB8FRQDVPXL.

PMID:
24619752
3.

Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious.

Schinstine M, Filie AC, Wilson W, Stetler-Stevenson M, Abati A.

Cancer. 2006 Jun 25;108(3):157-62.

4.

Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphoma.

Alvarez R, Dupuis J, Plonquet A, Christov C, Copie-Bergman C, Hemery F, Gaillard I, El Gnaoui T, Kuhnowski F, Bedoui M, Belhadj K, Brugières P, Haioun C.

Ann Oncol. 2012 May;23(5):1274-9. doi: 10.1093/annonc/mdr436. Epub 2011 Sep 30.

PMID:
21965472
5.

Lymphoid and myeloid neoplasms involving cerebrospinal fluid: comparison of morphologic examination and immunophenotyping by flow cytometry.

Roma AA, Garcia A, Avagnina A, Rescia C, Elsner B.

Diagn Cytopathol. 2002 Nov;27(5):271-5.

PMID:
12411991
6.

A systematic approach to the diagnosis of suspected central nervous system lymphoma.

Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA.

JAMA Neurol. 2013 Mar 1;70(3):311-9. doi: 10.1001/jamaneurol.2013.606. Review.

7.

CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.

Viaccoz A, Ducray F, Tholance Y, Barcelos GK, Thomas-Maisonneuve L, Ghesquières H, Meyronet D, Quadrio I, Cartalat-Carel S, Louis-Tisserand G, Jouanneau E, Guyotat J, Honnorat J, Perret-Liaudet A.

Neuro Oncol. 2015 Nov;17(11):1497-503. doi: 10.1093/neuonc/nov092. Epub 2015 May 25.

8.

Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era.

Sancho JM, Orfao A, Quijano S, García O, Panizo C, Pérez-Ceballos E, Deben G, Salar A, González-Barca E, Alonso N, García-Vela JA, Capote J, Peñalver FJ, Provencio M, Arias J, Plaza J, Caballero D, Morado M, Feliu E, Ribera JM; Spanish Group for the Study of CNS Disease in NHL.

Eur J Haematol. 2010 Oct;85(4):321-8. doi: 10.1111/j.1600-0609.2010.01478.x. Epub 2010 Jul 28.

PMID:
20528905
9.

Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report.

Taylor JW, Flanagan EP, O'Neill BP, Siegal T, Omuro A, Deangelis L, Baehring J, Nishikawa R, Pinto F, Chamberlain M, Hoang-Xuan K, Gonzalez-Aguilar A, Batchelor T, Blay JY, Korfel A, Betensky RA, Lopes MB, Schiff D.

Neurology. 2013 Nov 5;81(19):1690-6. doi: 10.1212/01.wnl.0000435302.02895.f3. Epub 2013 Oct 9.

10.
11.

Cerebrospinal fluid approach on neuro-oncology.

Gomes HR.

Arq Neuropsiquiatr. 2013 Sep;71(9B):677-80. doi: 10.1590/0004-282X20130149. Review.

13.
14.

Cerebrospinal fluid pleocytosis: pitfalls and benefits of combined analysis using cytomorphology and flow cytometry.

Bommer M, Nagy A, Schöpflin C, Pauls S, Ringhoffer M, Schmid M.

Cancer Cytopathol. 2011 Feb 25;119(1):20-6. doi: 10.1002/cncy.20127. Epub 2011 Jan 24.

15.

Lymphoma, leukemia, and pleiocytosis in cerebrospinal fluid: is accurate cytopathologic diagnosis possible based on morphology alone?

Wu JM, Georgy MF, Burroughs FH, Weir EG, Rosenthal DL, Ali SZ.

Diagn Cytopathol. 2009 Nov;37(11):820-4. doi: 10.1002/dc.21110.

PMID:
19526571
16.

Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis.

French CA, Dorfman DM, Shaheen G, Cibas ES.

Diagn Cytopathol. 2000 Dec;23(6):369-74.

PMID:
11074639
17.

Cytology of primary central nervous system neoplasms in cerebrospinal fluid specimens.

Chhieng DC, Elgert P, Cohen JM, Jhala NC, Cangiarella JF.

Diagn Cytopathol. 2002 Apr;26(4):209-12.

PMID:
11933264
18.

[Clinical diagnostic significance of cerebrospinal fluid detection with flow cytometry in children acute lymphoblastic leukemia accompanied by central nervous system leukemia].

Yang WY, Wang HJ, Chen YM, Chen XJ, Zou Y, Guo Y, Wang SC, Liu TF, Zhu XF.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Feb;20(1):38-42. Chinese.

PMID:
22391161
19.

Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma.

De Luca A, Antinori A, Cingolani A, Larocca LM, Linzalone A, Ammassari A, Scerrati M, Roselli R, Tamburrini E, Ortona L.

Br J Haematol. 1995 Aug;90(4):844-9. Erratum in: Br J Haematol 1995 Dec;91(4):1035.

PMID:
7669663
20.

Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.

Akpek EK, Ahmed I, Hochberg FH, Soheilian M, Dryja TP, Jakobiec FA, Foster CS.

Ophthalmology. 1999 Sep;106(9):1805-10.

PMID:
10485554

Supplemental Content

Support Center